Thyrocare Technologies Ltd (THYROCARE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000893,
    "name": "Thyrocare Tech.",
    "stock_name": "Thyrocare Tech.",
    "full_name": "Thyrocare Technologies Ltd",
    "name_url": "stocks-analysis/thyrocare-tech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "485.45",
    "chg": 16.85,
    "chgp": "3.6%",
    "dir": 1,
    "prev_price": "468.60",
    "mcapval": "8,122.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539871,
    "symbol": "THYROCARE",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE594H01019",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "1.17 cr",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/thyrocare-tech-1000893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Thyrocare Technologies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-thyrocare-technologies-ltd-latest-results-good-or-bad-3982348",
        "imagepath": "",
        "date": "2026-05-08 19:20:05",
        "description": "Thyrocare Technologies Ltd's latest financial results for the quarter ended March 2026 reflect a notable operational performance, showcasing significant growth in key metrics. The company reported a consolidated net profit of ₹47.12 crore, representing a substantial year-on-year growth of 117.14%. This impressive profit increase is complemented by a revenue figure of ₹223.95 crore, which marks a year-on-year growth of 19.66%. \n\nThe operating margin for this quarter reached 33.53%, indicating operational efficiency and the highest margin recorded to date, up from 30.83% in the previous year. This margin expansion is attributed to improved pricing power and effective cost management strategies. Additionally, the return on equity (ROE) stands at 23.91%, highlighting the company's strong capital efficiency.\n\nThyrocare's performance also indicates a sequential revenue growth of 14.53% from the previous quarter, ..."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Surge in Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-surge-in-value-trading-and-institutional-interest-3981223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_most_active_equities_by_value_3981223.png",
        "date": "2026-05-08 10:00:25",
        "description": "Thyrocare Technologies Ltd witnessed a remarkable surge in trading activity on 8 May 2026, emerging as one of the most actively traded stocks by value on the Indian equity markets. The healthcare services company recorded a substantial 8.21% gain in a single day, driven by robust institutional participation and a strong order flow that pushed the stock close to its 52-week high. This performance notably outpaced both its sector and the broader Sensex index, signalling renewed investor confidence in the small-cap healthcare player."
      },
      {
        "title": "Thyrocare Technologies Q4 FY26: Stellar Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/thyrocare-technologies-q4-fy26-stellar-profit-surge-masks-valuation-concerns-3981736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_quaterlyResult_3981736.png",
        "date": "2026-05-08 09:51:51",
        "description": "Thyrocare Technologies Ltd., India's leading diagnostic services provider, delivered a remarkable fourth-quarter performance for FY26, with consolidated net profit surging 117.14% year-on-year to ₹47.12 crores, significantly outpacing market expectations. The Mumbai-based company, commanding a market capitalisation of ₹7,908.13 crores, reported its highest-ever quarterly revenue of ₹223.95 crores, representing a 19.66% year-on-year growth and a robust 14.53% sequential improvement."
      },
      {
        "title": "Thyrocare Technologies Ltd Opens 5.62% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3981101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_gapup_3981101.png",
        "date": "2026-05-08 09:40:48",
        "description": ""
      },
      {
        "title": "Thyrocare Technologies Ltd Surges 11.57% to Day's High of Rs 521 — Outperforms Sector by 11.23 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-hits-intraday-high-with-1157-surge-on-8-may-2026-3981039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_priceRelatedfactors_3981039.png",
        "date": "2026-05-08 09:31:00",
        "description": "The Sensex declined 0.37% on 08 Jun 2026 while Thyrocare Technologies Ltd surged 11.57%, marking a remarkable 11.23-percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which has been on a notable upward trajectory in recent days."
      },
      {
        "title": "Thyrocare Technologies Ltd Upgraded to Buy on Strong Financials and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-upgraded-to-buy-on-strong-financials-and-technical-momentum-3980934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_mojoScore_3980934.png",
        "date": "2026-05-08 08:15:57",
        "description": "Thyrocare Technologies Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The company’s robust quarterly results, improved technical outlook, and consistent returns have driven this positive revision, signalling renewed investor confidence in the healthcare services firm."
      },
      {
        "title": "Thyrocare Technologies Ltd Shows Shift to Mildly Bullish Momentum Amid Technical Indicator Divergence",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-shows-shift-to-mildly-bullish-momentum-amid-technical-indicator-divergence-3980797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_technicaldot_3980797.png",
        "date": "2026-05-08 08:04:42",
        "description": "Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in this healthcare services small-cap stock."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3978928",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_technicaldot_3978928.png",
        "date": "2026-05-07 08:05:49",
        "description": "Thyrocare Technologies Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in price momentum, reflected in a 6.53% gain on 7 May 2026. Despite this surge, technical indicators present a nuanced picture, with some signalling bullish tendencies while others remain cautious, prompting a downgrade in the company’s Mojo Grade from Buy to Hold as of 4 March 2026."
      },
      {
        "title": "Thyrocare Technologies Ltd Surges 7.99% to Day's High of Rs 431.95 — Outperforms Sector by 4.66 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-hits-intraday-high-with-799-surge-on-4-may-2026-3974016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_priceRelatedfactors_3974016.png",
        "date": "2026-05-04 11:16:09",
        "description": "The Sensex advanced 0.98% on 4 May 2026, yet Thyrocare Technologies Ltd outpaced both the benchmark and its sector with a robust 7.99% gain, reaching an intraday high of Rs 431.95. This 4.66-percentage-point outperformance over the Hospital & Healthcare Services sector’s 3.77% rise signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      }
    ],
    "total": 319,
    "sid": "1000893",
    "stock_news_url": "https://www.marketsmojo.com/news/thyrocare-technologies-1000893"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On May 07 2026",
      "datetime": "07-May-2026",
      "details": "Please find enclosed the Outcome of the Board Meeting held on May 07 2026 inter alia for the approval of the Financial Results for the quarter and financial year ended March 31 2026 and other matters as detailed in the enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "07-May-2026",
      "details": "Please find attached press release on the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
      "datetime": "07-May-2026",
      "details": "Please refer the enclosed the intimation letter",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has declared <strong>70%</strong> dividend, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 28 Nov 25",
          "dt": "2025-11-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Thyrocare Technologies Ltd latest results good or bad?

2026-05-08 19:20:05

Thyrocare Technologies Ltd's latest financial results for the quarter ended March 2026 reflect a notable operational performance, showcasing significant growth in key metrics. The company reported a consolidated net profit of ₹47.12 crore, representing a substantial year-on-year growth of 117.14%. This impressive profit increase is complemented by a revenue figure of ₹223.95 crore, which marks a year-on-year growth of 19.66%. The operating margin for this quarter reached 33.53%, indicating operational efficiency and the highest margin recorded to date, up from 30.83% in the previous year. This margin expansion is attributed to improved pricing power and effective cost management strategies. Additionally, the return on equity (ROE) stands at 23.91%, highlighting the company's strong capital efficiency. Thyrocare's performance also indicates a sequential revenue growth of 14.53% from the previous quarter, ...

Read full news article

Thyrocare Technologies Ltd Sees Surge in Value Trading and Institutional Interest

2026-05-08 10:00:25

Thyrocare Technologies Ltd witnessed a remarkable surge in trading activity on 8 May 2026, emerging as one of the most actively traded stocks by value on the Indian equity markets. The healthcare services company recorded a substantial 8.21% gain in a single day, driven by robust institutional participation and a strong order flow that pushed the stock close to its 52-week high. This performance notably outpaced both its sector and the broader Sensex index, signalling renewed investor confidence in the small-cap healthcare player.

Read full news article

Thyrocare Technologies Q4 FY26: Stellar Profit Surge Masks Valuation Concerns

2026-05-08 09:51:51

Thyrocare Technologies Ltd., India's leading diagnostic services provider, delivered a remarkable fourth-quarter performance for FY26, with consolidated net profit surging 117.14% year-on-year to ₹47.12 crores, significantly outpacing market expectations. The Mumbai-based company, commanding a market capitalisation of ₹7,908.13 crores, reported its highest-ever quarterly revenue of ₹223.95 crores, representing a 19.66% year-on-year growth and a robust 14.53% sequential improvement.

Read full news article

Thyrocare Technologies Ltd Opens 5.62% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-05-08 09:40:48

Read full news article

Thyrocare Technologies Ltd Surges 11.57% to Day's High of Rs 521 — Outperforms Sector by 11.23 Percentage Points

2026-05-08 09:31:00

The Sensex declined 0.37% on 08 Jun 2026 while Thyrocare Technologies Ltd surged 11.57%, marking a remarkable 11.23-percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which has been on a notable upward trajectory in recent days.

Read full news article

Thyrocare Technologies Ltd Upgraded to Buy on Strong Financials and Technical Momentum

2026-05-08 08:15:57

Thyrocare Technologies Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The company’s robust quarterly results, improved technical outlook, and consistent returns have driven this positive revision, signalling renewed investor confidence in the healthcare services firm.

Read full news article

Thyrocare Technologies Ltd Shows Shift to Mildly Bullish Momentum Amid Technical Indicator Divergence

2026-05-08 08:04:42

Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in this healthcare services small-cap stock.

Read full news article

Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-07 08:05:49

Thyrocare Technologies Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in price momentum, reflected in a 6.53% gain on 7 May 2026. Despite this surge, technical indicators present a nuanced picture, with some signalling bullish tendencies while others remain cautious, prompting a downgrade in the company’s Mojo Grade from Buy to Hold as of 4 March 2026.

Read full news article

Thyrocare Technologies Ltd Surges 7.99% to Day's High of Rs 431.95 — Outperforms Sector by 4.66 Percentage Points

2026-05-04 11:16:09

The Sensex advanced 0.98% on 4 May 2026, yet Thyrocare Technologies Ltd outpaced both the benchmark and its sector with a robust 7.99% gain, reaching an intraday high of Rs 431.95. This 4.66-percentage-point outperformance over the Hospital & Healthcare Services sector’s 3.77% rise signals a distinctly stock-specific momentum shift rather than a mere market tailwind.

Read full news article

View All News